Chalcones: promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer AA WalyEldeen, S Sabet, HM El-Shorbagy, IA Abdelhamid, SA Ibrahim Chemico-Biological Interactions, 110297, 2023 | 52 | 2023 |
[1, 2, 4] Triazolo [3, 4-a] isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid … AA WalyEldeen, HM El-Shorbagy, HM Hassaneen, IA Abdelhamid, ... Naunyn-Schmiedeberg's archives of pharmacology 395 (10), 1225-1238, 2022 | 17 | 2022 |
Yttrium oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells B Emad, AA WalyEldeen, H Hassan, M Sharaky, IA Abdelhamid, ... BMC cancer 23 (1), 1151, 2023 | 5 | 2023 |
Nanoparticles as a therapeutic approach for tumor angiogenesis AAA Alghamdi, AA WalyEldeen, SA Ibrahim Innovative Approaches for Nanobiotechnology in Healthcare Systems, 52-113, 2022 | 3 | 2022 |
Correction: FBLN2 is associated with basal cell markers Krt14 and ITGB1 in mouse mammary epithelial cells and has a preferential expression in molecular subtypes of human … AA WalyEldeen, S Sabet, SE Anis, T Stein, AM Ibrahim Breast Cancer Research and Treatment, 1-1, 2024 | | 2024 |
FBLN2 is associated with basal cell markers Krt14 and ITGB1 in mouse mammary epithelial cells and has a preferential expression in molecular subtypes of human breast cancer AA WalyEldeen, S Sabet, SE Anis, T Stein, AM Ibrahim Breast Cancer Research and Treatment, 1-14, 2024 | | 2024 |